Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients’ cognitive framework

References

• World Health OrganizationAdherence to long-term therapiesGeneva, SwitzerlandWHO2003
   Google Scholar
• ShahNRHirschAGZackerCFactors associated with first-fill adherence rates for diabetic medications: a cohort studyJ Gen Intern Med200924223323719093157
   PubMed Web of Science ®Google Scholar
• CramerJA systematic review of adherence with medications for diabetesDiabetes Care20042791218122415111553
   PubMed Web of Science ®Google Scholar
• RubinRRAdherence to pharmacologic therapy in patients with type 2 diabetes mellitusAm J Med2005118Suppl 5A27S35S15850551
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMFactors affecting use of insulin pens by patients with type 2 diabetesDiabetes Care200831343043218039802
   PubMed Web of Science ®Google Scholar
• KravitzRLEpsteinRMFeldmanMDInfluence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trialJAMA2005293161995200215855433
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRPhysician perception and recommendation of insulin pens for patients with type 2 diabetesCurr Med Res Opin20082482413242218627641
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRLauritzenTResistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs study (DAWN)Diabetes Care200528112673267916249538
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMQuality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a pre-mixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategiesDiabetes Care200427102495249715451924
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRValidity and reliability of an instrument for assessing health-related quality of life and treatment preference: the Insulin Delivery System Rating QuestionnaireDiabetes Care2005281535815616233
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRHow does treatment satisfaction work?: modeling determinants of treatment satisfaction and preferenceDiabetes Care20093281411141719470837
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMKrugerDTravisLBarriers to insulin injection therapy: patient and health care provider perspectivesDiabetes Educator20093561014102219934459
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRKrugerDTravisLCorrelates of insulin injection omissionDiabetes Care2010332243248
   Web of Science ®Google Scholar
• PeyrotMRubinRREffect of Technosphere inhaled insulin on quality of life and treatment satisfactionDiabetes Technol Therapeutics20101214955
   PubMed Web of Science ®Google Scholar
• FreemantleNBlondeLDuhotDAvailability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetesDiabetes Care200528242742815677807
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRPerceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients’ cognitive frameworkDiabetes201059Suppl 1A52
   Google Scholar
• RosenstockJBergenstalRDeFronzoRAEfficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naïve type 2 diabetes suboptimally controlled with oral agentsDiabetes Care200831112177218218678610
   PubMed Web of Science ®Google Scholar
• RosenstockJLorberDLGnuidiLPrandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomized trialLancet201037597332244225320609970
   PubMed Web of Science ®Google Scholar
• AminVBossAHPetrucciREPulmonary functions (over 2 years) in diabetic subjects treated with Afresa™ or usual antidiabetic treatmentDiabetes200958Suppl 1A153
   Google Scholar
• HeinemannLHeiseTCurrent status of the development of inhaled insulinBr J Diabetes Vascular Dis200445295301
   Google Scholar
• PeyrotMSkovlundSLandgrafREpidemiology and correlates of weight worry in the multi-national Diabetes Attitudes, Wishes and Needs (DAWN) StudyCurr Med Res Opin20092581985199319555311
   PubMed Web of Science ®Google Scholar
• MakineCKarsidagCKadiogluPSymptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research ConsortiumDiabet Med2009261283319125757
   PubMed Web of Science ®Google Scholar
• PeyrotMMcMurryJFHedgesRLiving with diabetes: the role of personal and professional knowledge in symptom and regimen managementRothJConradPResearch in the Sociology of Health Care6Greenwich, CTJAI Press1987107146
   Google Scholar
• CoxDJIrvineAGonder-FrederickLFear of hypoglycemia: quantification, validation, and utilizationDiabetes Care19871056176213677982
   PubMed Web of Science ®Google Scholar
• Del PratoSBlondeLMartinezLThe effect of the availability of inhaled insulin on glycaemic control in patients with type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practiceDiabet Med200825666267018435781
   PubMed Web of Science ®Google Scholar
• GuimarãesCMarraCAGillSA discrete choice experiment evaluation of patients’ preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes managementPatient Prefer Adherence2010443344021301591
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMFactors associated with physician perceptions of and willingness to recommend inhaled insulinCurrent Med Res Opin2011272285294
   PubMed Web of Science ®Google Scholar